martes, 4 de febrero de 2020

Most innovative cancer drugs take too long to reach patients in the U.K.

Most innovative cancer drugs take too long to reach patients in the U.K.

Cancer Briefing



STAT Plus: Most innovative cancer drugs take too long to reach patients in the U.K.

By ED SILVERMAN


DANIEL LEAL-OLIVAS/AFP/GETTY IMAGES
The analysis found that one key problem is drug makers generated an insufficient number of new treatments for cancers with the highest unmet medical need.

No hay comentarios: